Aug 11, 2021 / 08:30PM GMT
Operator
Good afternoon, and welcome to Evofem Biosciences Second Quarter 2021 Results Call.
(Operator Instructions)
Please be advised that today's conference is being recorded. I would now like to turn the call over to Evofem's Vice President of Investor Relations, Amy Raskopf.
Amy Raskopf - Evofem Biosciences, Inc. - VP of IR
Thank you, and good afternoon, everyone. If you haven't done so already, I encourage you to access the Second Quarter of 2021 presentation and the press release we have issued earlier today, both of which are at evofem.com under the Investors tab. Before we begin, I would like to remind you that remarks on this call will contain forward-looking statements, which are made only as of today, August 11, 2021. For a more detailed description of important risk factors that could cause our actual results to differ materially. Please refer to our annual report on Form 10-K and our most recently filed 10-Q.
With that, I'll turn the call over to Saundra Pelletier, Evofem's CEO.
Saundra Pelletier -
Q2 2021 Evofem Biosciences Inc Earnings Call Transcript
Feb 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers